Giving that lidocaine is often used in ovarian cancer surgery, this study aimed to investigate whether lidocaine could inhibit the malignancy of ovarian cancer through blocking NaV1.5 and the associated mechanisms. This evidence concerns the gene SCN5A and ovarian cancer.